
ProRelix Research is a franchise brand in the Pharmacies sector in India, established in 2014 and franchising since 2015. A new unit needs an investment of ₹2L - 5L and 250 - 500 sq ft of space. It has less than 10 outlets and is headquartered in Pune, Maharashtra. The brand is expanding in Maharashtra.
ProRelix Research is a clinical research services company from Pune, Maharashtra, set up in 2014 and franchising since 2015. It works in clinical data management, regulatory affairs, medical writing, pharmacovigilance and clinical trial support. A franchise unit needs 250–500 sq ft and an investment of ₹2–5 lakh, according to the brand. Training is at its head office.
ProRelix Research is a clinical research organisation based in Pune, Maharashtra, operating through ProRelix Services LLP. It has been working since 2014 and began franchising in 2015. It supports pharmaceutical and medical device companies with services linked to drug development.
Services named by the brand include:
The company says it also offers tools to help recruit patients and investigators, and works through pharmaceutical and medical device teams. It reports fewer than 10 outlets.
The brand states an investment of ₹2–5 lakh for a unit. A franchise fee and royalty are not stated. The brand estimates a payback of about 1 year and an ROI of 40%. These are its own estimates. As a services business, income depends on winning contracts or work from clients, so ask how leads are generated for franchisees.
The format is a single unit of 250–500 sq ft. The brand shows pan-India as a preferred location and Maharashtra as its stated expansion area. The agreement runs 5 years and is renewable.
The brand lists opening support, with training held at its head office. Other support details such as manuals or IT systems are not specified.
This is a specialist business. It suits people with a life sciences, pharmacy, medical or clinical research background who can work with pharmaceutical clients and teams. It is not designed for a general retail investor.
| Total investment | ₹2L - 5L |
|---|---|
| Unit franchise investment | ₹2L - 5L |
| Payback period | 1 year |
| Expected ROI | 40% |
| Space required | 250 - 500 sq ft |
| Preferred locations | PAN INDIA |
| Agreement term | 5 years (renewable) |
| Training provided | Yes |
|---|---|
| Training location | Head office |
| Opportunity type | Franchise |
|---|---|
| Franchise model | Unit |
| Headquarter | Pune, Maharashtra |
| Established | 2014 |
| Franchising since | 2015 |
| Franchise outlets | Less than 10 |
A ProRelix Research franchise needs an investment of ₹2–5 lakh for a unit, according to the brand.
ProRelix Research estimates a payback of about 1 year and an ROI of 40%. These are the brand's own estimates and not guaranteed.
A ProRelix Research franchise unit needs about 250–500 sq ft, as stated by the brand.
ProRelix Research provides clinical research services, including data management, regulatory affairs, medical writing, pharmacovigilance and clinical trial support.
ProRelix Research is headquartered in Pune, Maharashtra. It was set up in 2014 and started franchising in 2015.
ProRelix Research holds franchisee training at its head office, according to the brand.
The ProRelix Research franchise agreement runs for 5 years and is renewable, as stated by the brand.
To apply for a ProRelix Research franchise, send an enquiry with the "I'm interested" button on this page and discuss your background with the brand.
Last updated . Information is compiled from public sources and brand submissions and may change — verify the details with ProRelix Research before investing.


